Stem Cell Stocks Updated

LAST WEEK I suggested that the upcoming elections could be beneficial to companies involved in stem cell research. I have been most bullish and have “official” positions open in STEM from $2.27 and ASTM from $1.27. The stocks are approaching the target areas at the declining 200 day moving averages (2.70 for STEM and 1.50 for ASTM) and I think it is now prudent to significantly reduce your positions (I just sold the last of mine). Do not fall in love with the stocks, we may revisit them again, but I believe the best course of action is to lock in profits here.